摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(isothiocyanatomethyl)benzoic acid | 35009-14-4

中文名称
——
中文别名
——
英文名称
4-(isothiocyanatomethyl)benzoic acid
英文别名
——
4-(isothiocyanatomethyl)benzoic acid化学式
CAS
35009-14-4
化学式
C9H7NO2S
mdl
——
分子量
193.226
InChiKey
YJHAFHMZBVQRFC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    172 °C(Solv: ethyl acetate (141-78-6))
  • 沸点:
    377.1±25.0 °C(Predicted)
  • 密度:
    1.23±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    81.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(isothiocyanatomethyl)benzoic acid吡啶草酰氯N,N-二甲基甲酰胺 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 37.5h, 生成 (R)-tert-butyl N-(2-(4-((3-(2-hydroxy-2-phenylethyl)thioureido)methyl)benzamido)phenyl)carbamate
    参考文献:
    名称:
    Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit
    摘要:
    A novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contains an oxazoline capping group and a N-(2-aminophenyl)-benzamide unit. Among several new inhibitors of this type exhibiting Class I selectivity and potent inhibition of HDAC3-NCoR2, in vitro assays for the inhibition of HDAC1, HDAC2, and HDAC3-NCoR2 by N-(2-aminophenyl)-benzamide 15k gave respective IC50 values of 80, 110, and 6 nM. Weak inhibition of all other HDAC isoforms (HDAC4, 5, 6, 7, and 9: IC50 > 100 000 nM; HDAC8: IC50 = 25 000 nM; HDAC10: IC50 > 4000 nM; HDAC11: IC50 > 2000 nM) confirmed the Class I selectivity of 15k 2-Aminoimidazolinyl, 2-thioimidazolinyl, and 2-aminooxazolinyl units were shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)-benzamides previously reported, but the 2-aminooxazolinyl unit was the most potent in inhibiting HDAC3-NCoR2. Many of the new HDAC inhibitors showed higher solubilities and lower binding to human serum albumin than that of Mocetinostat. Increases in histone H3K9 acetylation in the human cell lines U937 and PC-3 was observed for all three oxazolinyl inhibitors evaluated; those HDAC inhibitors also lowered cyclin E expression in U937 cells but not in PC-3 cells, indicating underlying differences in the mechanisms of action of the inhibitors on those two cell lines.
    DOI:
    10.1021/acs.jmedchem.5b00545
  • 作为产物:
    描述:
    二硫化碳4-氨甲基苯甲酸三乙胺盐酸 作用下, 以 四氢呋喃 为溶剂, 反应 26.07h, 生成 4-(isothiocyanatomethyl)benzoic acid
    参考文献:
    名称:
    EP2248800
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Facile synthesis of aliphatic isothiocyanates and thioureas on solid phase using peptide coupling reagents
    作者:Ulrik Boas、Heidi Gertz、Jørn B. Christensen、Peter M.H. Heegaard
    DOI:10.1016/j.tetlet.2003.10.182
    日期:2004.1
    Peptide coupling reagents can be used as versatile reagents for the formation of aliphatic isothiocyanates and thioureas on solid phase from the corresponding solid-phase anchored aliphatic primary amines. The formation of the thioureas is fast and highly chemoselective, and proceeds via formation of the intermediate isothiocyanate. The isothiocyanate and subsequent thiourea formation take place under
    肽偶联剂可用作通用试剂,用于由相应的固相锚定的脂族伯胺在固相上形成脂族异硫氰酸酯和硫脲。硫脲的形成是快速且高度化学选择性的,并且通过中间体异硫氰酸酯的形成而进行。异硫氰酸酯和随后的硫脲的形成在标准肽偶联条件下进行,使用二硫化碳作为“氨基酸”。硫脲从树脂中释放出来,并以中等至高收率分离。
  • Process for preparing peptide derivatized oligomeric compounds
    申请人:——
    公开号:US20020156235A1
    公开(公告)日:2002-10-24
    Methods of preparing peptide linked oligomeric compounds are provided. The method is useful for preparing larger scale amounts of peptide linked oligomeric compounds. More particularly, the synthesis of peptide linked oligomeric compounds is performed without the problems of aggregation associated with electrostatic interactions. The present method describes using equimolar amounts of oligomeric compounds and peptide reagents providing for an increase in overall efficiency.
    提供了制备肽链寡聚化合物的方法。该方法适用于制备规模较大的肽链寡聚化合物。更具体地说,肽链寡聚化合物的合成是在没有与静电相互作用有关的聚集问题的情况下进行的。本方法描述了使用等摩尔量的寡聚化合物和肽试剂,从而提高了整体效率。
  • Method for producing isothiocyanate compound having carboxyl group
    申请人:Nakano Satoshi
    公开号:US08367857B2
    公开(公告)日:2013-02-05
    To provide a novel method for producing an isothiocyanate compound having a carboxyl group(s) from the corresponding amino compound having a carboxyl group(s). A method for producing an isothiocyanate compound which has a carboxyl group(s) and is represented by the formula (2). And the method comprises reacting an amino compound which has a carboxyl group(s) and is represented by the formula (1) (wherein A is e.g. a C6-14 aromatic hydrocarbon group or a C1-12 saturated hydrocarbon group, and B is e.g. a single bond, a C6-14 aromatic hydrocarbon group or a C1-12 saturated hydrocarbon group), in a solvent, with carbon disulfide (CS2) and then with a halogen as a simple substance.
    提供一种从具有羧基的相应氨基化合物中产生具有羧基的异硫氰酸酯化合物的新方法。一种产生具有羧基的异硫氰酸酯化合物的方法,该化合物由公式(2)表示。该方法包括在溶剂中反应具有羧基的氨基化合物,该氨基化合物由公式(1)表示(其中A为例如C6-14芳香烃基或C1-12饱和烃基,B为例如单键,C6-14芳香烃基或C1-12饱和烃基),然后与二硫化碳(CS2)和卤素作为简单物质反应。
  • METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP
    申请人:Nakano Satoshi
    公开号:US20100312000A1
    公开(公告)日:2010-12-09
    To provide a novel method for producing an isothiocyanate compound having a carboxyl group(s) from the corresponding amino compound having a carboxyl group(s). A method for producing an isothiocyanate compound which has a carboxyl group(s) and is represented by the formula (2). And the method comprises reacting an amino compound which has a carboxyl group(s) and is represented by the formula (1) (wherein A is e.g. a C 6-14 aromatic hydrocarbon group or a C 1-12 saturated hydrocarbon group, and B is e.g. a single bond, a C 6-14 aromatic hydrocarbon group or a C 1-12 saturated hydrocarbon group), in a solvent, with carbon disulfide (CS2) and then with a halogen as a simple substance.
    提供一种新的方法,用于从具有羧基(s)的相应氨基化合物制备具有羧基(s)的异硫氰酸酯化合物。一种用于生产具有羧基(s)的异硫氰酸酯化合物的方法,其表示为公式(2)。该方法包括在溶剂中反应具有羧基(s)的氨基化合物,其表示为公式(1)(其中A是例如C6-14芳香族碳氢基团或C1-12饱和碳氢基团,B是例如单键,C6-14芳香族碳氢基团或C1-12饱和碳氢基团),与二硫化碳(CS2)然后与卤素作为简单物质。
  • Grabenko,A.D. et al., Journal of Organic Chemistry USSR (English Translation), 1972, vol. 8, p. 532 - 534
    作者:Grabenko,A.D. et al.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐